Vaccinex (VCNX) SEC Filings & 10K Form $0.71 -0.04 (-5.33%) As of 08/7/2025 10:07 AM Eastern Add Compare Share Share SEC Filings Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Recent Vaccinex SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel DateFilerForm TypeView04/15/20254:12 PMVaccinex (Filer)Form 10-KAnnual report pursuant to Section 13 or 15(d) 04/01/20256:01 AMVaccinex (Filer)Form NT 10-K03/27/20257:24 AMVaccinex (Filer)Form 15-12G03/25/202511:15 PMVaccinex (Filer)Form EFFECT03/25/202511:15 PMVaccinex (Filer)Form EFFECT03/25/202511:15 PMVaccinex (Filer)Form EFFECT03/25/202511:15 PMVaccinex (Filer)Form EFFECT03/25/202511:15 PMVaccinex (Filer)Form EFFECT03/25/202511:15 PMVaccinex (Filer)Form EFFECT03/25/202511:15 PMVaccinex (Filer)Form EFFECT03/25/202511:15 PMVaccinex (Filer)Form EFFECT Get the Latest News and Ratings for VCNX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vaccinex and its competitors with MarketBeat's FREE daily newsletter. 03/25/202511:15 PMVaccinex (Filer)Form EFFECT03/25/202511:15 PMVaccinex (Filer)Form EFFECT03/25/202511:15 PMVaccinex (Filer)Form EFFECT03/25/202511:15 PMVaccinex (Filer)Form EFFECT03/25/202511:15 PMVaccinex (Filer)Form EFFECT03/25/202511:15 PMVaccinex (Filer)Form EFFECT03/25/202511:15 PMVaccinex (Filer)Form EFFECT03/25/20257:38 AMVaccinex (Filer)Form POS AM03/25/20257:40 AMVaccinex (Filer)Form POS AM03/25/20257:41 AMVaccinex (Filer)Form POS AM03/25/20257:43 AMVaccinex (Filer)Form POS AM03/25/20257:45 AMVaccinex (Filer)Form POS AM03/25/20257:46 AMVaccinex (Filer)Form POS AM03/25/20257:48 AMVaccinex (Filer)Form POS AM03/25/20257:50 AMVaccinex (Filer)Form POS AM03/25/20257:51 AMVaccinex (Filer)Form POS AM03/25/20257:24 AMVaccinex (Filer)Form S-8 POS03/25/20257:26 AMVaccinex (Filer)Form S-8 POS03/25/20257:28 AMVaccinex (Filer)Form POS AM03/25/20257:30 AMVaccinex (Filer)Form POS AM03/25/20257:31 AMVaccinex (Filer)Form POS AM03/25/20257:34 AMVaccinex (Filer)Form POS AM03/25/20257:35 AMVaccinex (Filer)Form POS AM03/25/20257:36 AMVaccinex (Filer)Form POS AM03/19/20253:15 PMVaccinex (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 03/07/20254:21 PMVaccinex (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 02/14/20253:43 PMARMISTICE CAPITAL, LLC (Filed by)Vaccinex (Subject)Form SCHEDULE 13G/A12/17/20248:32 AMVaccinex (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 11/18/20243:15 PMVaccinex (Subject)Zauderer Maurice (Filed by)Form SC 13D/A10/25/20243:11 PMVaccinex (Filer)Form 424B3Trump’s national nightmare is here (Ad)Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.Watch the National Emergency broadcast here10/24/202411:15 PMVaccinex (Filer)Form EFFECT10/16/20243:44 PMVaccinex (Filer)Form S-3Registration statement under Securities Act of 1933 10/09/20243:37 PMVaccinex (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 09/27/20243:11 PMVaccinex (Filer)Form DNotice of Exempt Offering of Securities 09/20/20244:15 PMFCMI Parent Co. (Filed by)Vaccinex (Subject)Form SC 13D/A09/20/20243:57 PMVaccinex (Subject)Zauderer Maurice (Filed by)Form SC 13D/A09/19/20247:30 AMVaccinex (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 08/20/20245:04 AMVaccinex (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 08/14/20244:17 PMVaccinex (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 08/14/20247:35 AMVaccinex (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) (Data available from 1/1/2016 forward) Related Companies and Tools Related Companies Traws Pharma SEC Filings Novogen SEC Filings Talphera SEC Filings Turnstone Biologics SEC Filings GENPREX SEC Filings Biomerica SEC Filings AEON Biopharma SEC Filings Synaptogenix SEC Filings ObsEva SEC Filings Evoke Pharma SEC Filings SEC Filings Tools Latest SEC FilingsInsider Trading Activity This page (NASDAQ:VCNX) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vaccinex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vaccinex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VCNX Stock Alerts